Business
Currency:JPY
2024/FY
Stock NameRevenueRatio
Research and development, purchasing, manufacturing, and sales of prescription pharmaceuticals, as435.08B100.00%
Region
Currency:JPY
2024/FY
Stock NameRevenueRatio
United Kingdom201.29B46.26%
Japan155.28B35.69%
Profits from license transfer25.01B5.75%
United States18.03B4.14%
Others17.77B4.08%
Europe17.7B4.07%
North America5M0.00%
View all
